Craft

BD

Stock Price

$237.5

2024-10-29

Market Capitalization

$68.7 B

2024-10-29

Revenue

$20.2 B

FY, 2024

BD Summary

Company Summary

Overview
BD (Becton, Dickinson and Company) is a medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. It operates through three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment offers medication delivery and management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the collection and transport of diagnostics specimens and instruments and reagent systems that detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment produces vascular, urology, oncology, and surgical specialty products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, pharma, and other industries.
Type
Public
Status
Active
Founded
1897
HQ
Franklin Lakes, NJ, US | view all locations
Website
https://www.bd.com/en-us
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Tom Polen

    Tom Polen, Chairman, Chief Executive Officer, and President

  • Christopher DelOrefice

    Christopher DelOrefice, Executive Vice President and Chief Financial Officer

  • Ronald Silverman

    Ronald Silverman, Executive Vice President and Chief Medical Officer

  • Elizabeth McCombs

    Elizabeth McCombs, Executive Vice President and Chief Technology Officer

Operating MetricsView all

Facility Space Leased, sq. ft.

8M
1.0%

FY, 2023

Business Segments

3

FY, 2023

Facility Space Owned, sq. ft.

18.1M
2.9%

FY, 2023

LocationsView all

93 locations detected

  • Franklin Lakes, NJ HQ

    United States

    1 Becton Drive

  • Andover, MA

    United States

    200 Bulfinch Dr

  • Broken Bow, NE

    United States

    150 S 1st Ave

  • Canaan, CT

    United States

    7 Grace Way

  • Cockeysville, MD

    United States

    250 Schilling Cir, Hunt Valley

  • Columbus, NE

    United States

    920 19th St E

and 87 others

BD Financials

Summary Financials

Revenue (Q1, 2025)
$5.2B
Gross profit (Q1, 2025)
$2.2B
Net income (Q1, 2025)
$303.0M
Cash (Q1, 2025)
$711.0M
EBIT (Q1, 2025)
$453.0M
Enterprise value
$86.7B

Footer menu